Fred Hassan
Insider Reports History
- Location
- Boca Raton, FL
- Signature
- /s/ Fred Hassan, by Donald P. Lehr, as attorney-in-fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Fred Hassan:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PRECIGEN, INC. | Director | Common Stock | 1,243,239 | $5,892,952 | $4.74 | 13 Mar 2026 | Direct |
| Cocrystal Pharma, Inc. | Director | Common Stock | 1,383,009 | $1,922,382 | $1.39 | 28 Oct 2025 | Direct |
| Cocrystal Pharma, Inc. | Director | Warrants | 719,426 | $1,000,002 | $1.39 | 28 Oct 2025 | Direct |
| BridgeBio Pharma, Inc. | Director | Common Stock | 25,889 | $850,194 | $32.84 | 20 Jun 2025 | Direct |
| PRECIGEN, INC. | Director | Restricted Stock Units | 0 | $0 | $1.74 | 13 Mar 2026 | Direct |
| PRECIGEN, INC. | Director | Option to Purchase Common Stock (Right to Buy) | 41,073 | 10 Mar 2026 | Direct | ||
| EyePoint, Inc. | Director | Stock Option (Right to Buy) | 40,000 | 02 Jan 2026 | Direct | ||
| Cocrystal Pharma, Inc. | Director | Stock Options (Right to Buy) | 16,410 | 09 Jan 2026 | Direct | ||
| BridgeBio Pharma, Inc. | Director | Stock Option (Right to Buy) | 8,425 | 20 Jun 2025 | Direct | ||
| Prometheus Biosciences, Inc. | Director | Common Stock | 0 | $108.42 | 16 Jun 2023 | Direct | |
| Prometheus Biosciences, Inc. | Director | Stock Option (right to buy) | 0 | 16 Jun 2023 | Direct |